What are peptides? They are short chains of amino acids joined by peptide (amide) bonds, conventionally containing between two and roughly fifty residues and with molecular weights below about 5 kDa. They differ from proteins mainly in size and in the extent of stable tertiary folding. In the laboratory, peptides are used as receptor ligands, enzyme substrates and inhibitors, antigens, analytical standards and structural probes. This article explains their chemistry, how they interact with biological targets, how they are made, what the landmark literature shows, and which purity and handling requirements affect the reliability of laboratory data.
What are peptides?
A peptide is a polymer of α-amino acids in which the carboxyl group of one residue forms an amide bond with the amino group of the next. The bond is planar and has partial double-bond character, which restricts rotation and usually places the adjacent atoms in a trans arrangement. These constraints, together with the side chains of the twenty proteinogenic amino acids, determine how a chain folds and what it can bind. Peptide sequences are written from the free amino terminus (N-terminus) to the carboxyl terminus (C-terminus). Many bioactive peptides have an amidated C-terminus, which removes a negative charge and often improves stability and receptor affinity.
Terminology varies. Two residues make a dipeptide, short chains of up to about ten are called oligopeptides, and longer chains are often called polypeptides. The boundary between peptide and protein is conventional rather than absolute. Insulin, with 51 residues in two chains linked by disulfide bonds, sits at the edge of the range, and the term is applied according to context. The average residue mass is about 110 Da, so a ten-residue peptide weighs roughly 1.1 kDa, and a 29-residue chain weighs about 3.3 kDa.
Peptides occur widely in nature. Glutathione is a tripeptide, oxytocin is a nine-residue peptide hormone of about 1,007 Da, and the endogenous ghrelin molecule has 28 residues. Some are produced by ribosomal synthesis and processed from larger precursors, while others, including many microbial products, are made by non-ribosomal peptide synthetases and may contain D-amino acids or cyclic structures. Chemists add further modifications to tune stability and selectivity, including N-terminal acetylation, C-terminal amidation, cyclisation, lipidation, and the substitution of L-residues with D-residues or non-natural amino acids.
The history of the field is short and well documented. Emil Fischer and Ernest Fourneau reported the first synthetic dipeptide, glycylglycine, in 1901, and Fischer proposed the term “peptide” soon after. Frederick Sanger’s determination of the amino acid sequence of insulin in the 1950s showed that a protein hormone has a defined, reproducible primary structure, work that earned him the 1958 Nobel Prize in Chemistry.
Mechanism of action
Peptides act through molecular recognition. A peptide binds a specific partner, most often a receptor, enzyme or antibody, through a combination of electrostatic contacts, hydrogen bonds and hydrophobic packing. Short peptides are usually flexible in solution and adopt a defined conformation, such as an α-helix or β-turn, only when bound.
The largest group of peptide receptors are G protein-coupled receptors (GPCRs). In many peptide hormone systems the C-terminal portion of the ligand engages the receptor’s extracellular domain and the N-terminal region reaches into the transmembrane core to trigger activation. The activated receptor couples to heterotrimeric G proteins, for example Gs and cyclic AMP in some systems and Gq/11 with calcium mobilisation in others. Other peptides, such as insulin, activate receptor tyrosine kinases, while some act on ion channels or inhibit enzymes by occupying the active site.
Understanding what are peptides at the molecular level also means recognising how short-lived they are. Peptidases in plasma and tissue cleave them rapidly, and dipeptidyl peptidase-IV, for example, removes N-terminal dipeptides from several hormone peptides. This is why chemists introduce D-amino acids or terminal modifications: these changes block recognition by proteases and extend persistence in assays containing serum or tissue. Short exposure time is a property to be controlled in experimental design, not a flaw, because it determines how long receptor occupancy lasts in a culture.
What the research shows
Four sets of published work frame the field.
The first is the chemical synthesis of the first peptide bond-linked molecules. Fischer and Fourneau prepared glycylglycine in 1901, establishing that amino acids could be joined deliberately in the laboratory. The work is historical, but it created the basis for the later development of coupling chemistry and protecting groups.
The second is the first synthesis of a peptide hormone. Vincent du Vigneaud and colleagues reported in the Journal of the American Chemical Society in 1953 the synthesis of an octapeptide amide with the hormonal activity of oxytocin, which was followed by his award of the 1955 Nobel Prize in Chemistry. The result demonstrated that a synthetic molecule could reproduce the activity of an isolated natural hormone, and it gave chemists a way to test structure-activity relationships by changing one residue at a time.
The third is the invention of solid-phase peptide synthesis. R. B. Merrifield described in 1963 the stepwise assembly of a model tetrapeptide on an insoluble polystyrene resin, an approach that allowed excess reagents and by-products to be removed by simple washing. This method became the standard route to research peptides, and he received the Nobel Prize in Chemistry in 1984. A curated list of the foundational solid-phase papers, hosted by the University of Delaware, is available at the Peptide Synthesis Resource at the University of Delaware.
The fourth is the identification of an endogenous peptide ligand through work that began with synthetic compounds. Kojima and colleagues reported in Nature in 1999 the purification from rat stomach of a 28-residue acylated peptide, ghrelin, that is the natural ligand of a receptor previously known only through synthetic growth hormone secretagogues, and they showed that octanoylation at serine 3 was essential for its activity. The paper illustrates how synthetic peptide tools can lead to the discovery of natural signalling molecules and is indexed on PubMed.
Research applications
Peptides serve several distinct laboratory roles. In receptor pharmacology, defined synthetic ligands are applied to transfected cell lines or primary cells to characterise signalling through cAMP, calcium, ERK or other readouts, and analogues with single substitutions are compared to map which residues matter. Researchers who ask what are peptides used for in this setting usually have a ligand-receptor experiment in mind.
Enzymology is a second area. Short peptides act as substrates for proteases and kinases, often with a fluorophore and quencher attached, so that cleavage or phosphorylation can be followed in real time, and peptide-based inhibitors are used to probe active-site specificity. Immunology uses peptides as antigens and epitope probes, for example in antibody mapping and T-cell stimulation assays.
Structural and biophysical studies use peptides as small, tractable models of protein folding, helix formation and membrane interaction, studied by circular dichroism, NMR and fluorescence methods. Analytical chemistry is a fourth area: well-characterised peptides serve as standards for HPLC and mass spectrometry, for calibrating instruments, validating methods and testing forced-degradation conditions. Finally, materials and cell-culture research uses designed self-assembling peptides to build scaffolds and hydrogels.
Purity, storage and handling
Peptides are produced by solid-phase synthesis, cleaved from the resin with strong acid, purified by preparative reversed-phase HPLC and then lyophilised. Each stage can introduce impurities, including deletion sequences, truncated chains, racemised residues, residual protecting groups and oxidised species. Verification therefore relies on more than one method. Analytical reversed-phase HPLC, monitored at 214 nm for the peptide bond, gives purity by peak area, and mass spectrometry confirms that the intact mass matches the theoretical value. Amino acid analysis or quantitative nitrogen analysis can establish net peptide content, which matters because a vial contains peptide, counter-ions and bound water, so gross weight overstates the amount of active molecule.
Because degradation accelerates once reconstituted, batch-level HPLC verification matters more here than with more stable compounds. A clear grasp of What Are Peptides in chemical terms makes supplier assessment easier, and UK laboratories comparing the best peptides supplier uk options should expect a batch-specific certificate of analysis and lyophilised storage at -20°C.
A batch-specific certificate matters because impurity profiles differ between synthesis runs even when the sequence is identical. The certificate should state the batch number, the HPLC conditions, the observed mass, the test date and the salt form. Trifluoroacetate is the usual counter-ion after HPLC purification, and it can affect cell viability and proliferation assays, so exchange to acetate or hydrochloride is common for biological work. Endotoxin testing is relevant for any cell-based use, since lipopolysaccharide can trigger signalling responses that confound results.
Lyophilised peptides are generally stored at -20°C, sealed and desiccated, with colder storage for long periods and for sequences known to be unstable. Many peptides are hygroscopic, so vials should reach room temperature before opening to avoid condensation. Reconstituted solutions are much less stable than the dry powder. Methionine and cysteine are prone to oxidation, asparagine and glutamine can deamidate, aspartate-proline bonds are acid-labile, and hydrophobic sequences may aggregate or adsorb to plastic surfaces. Stock solutions are therefore normally kept at 2-8°C for short periods and divided into single-use aliquots to avoid repeated freeze-thaw cycles, with low-binding tubes used at low concentrations. Stability windows depend on sequence, pH, buffer and concentration, so they should be taken from supplier data and checked in-house for critical assays.
Light sensitivity varies with sequence. Peptides containing tryptophan, tyrosine or other aromatic or sulfur-containing residues can undergo photo-oxidation, so amber vials or dark storage are advisable for both powder and solutions.
Frequently asked questions
What are peptides used for in laboratory research?
Peptides are used as receptor ligands, enzyme substrates and inhibitors, antigens for antibody production, analytical standards and building blocks in structural studies. In cell-based work they allow signalling pathways to be probed with a defined, chemically synthesised molecule, which makes results easier to reproduce than with crude biological extracts.
What is the difference between a peptide and a protein?
The distinction is conventional rather than absolute. Chains of up to roughly 50 amino acids, or about 5 kDa, are usually called peptides, while longer chains that fold into stable tertiary structures are called proteins. Insulin, at 51 residues across two chains, sits on the boundary, so context and function often decide the label.
How are research peptides made?
Most research peptides are made by solid-phase peptide synthesis, in which the chain is built one residue at a time on an insoluble resin, then cleaved, purified by preparative HPLC and lyophilised. Longer or modified molecules may be made by recombinant expression or by chemical ligation of fragments.
How should lyophilised peptides be stored?
Lyophilised peptides are typically stored at -20°C, sealed, desiccated and protected from light, and warmed to room temperature before opening. Reconstituted solutions are far less stable, so they are usually kept at 2-8°C briefly and aliquoted to avoid freeze-thaw cycles, with limits confirmed from batch documentation.
Peptides described in this article are supplied for in-vitro laboratory research only. They are not for human or veterinary use, and they must not be administered to people or animals.
